The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: This study aimed to identify clinical features associated with premature mortality in a large contemporary cohort of adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The Finnish Diabetic Nephropathy (FinnDiane) study is a national multicenter prospective follow-up study of 4,201 adults with type 1 diabetes from 21 university and central hospitals, 33 district hospitals, and 26 primary health care centers across Finland. RESULTS: During a median 7 years of follow-up, there were 291 deaths (7%), 3.6-fold (95% CI 3.2–4.0) more than that observed in the age- and sex-matched general population. Excess mortality was only observed in individuals with chronic kidney disease. Individuals with normoalbuminuria showed no excess mortality beyond the general population (standardized mortality ratio [SMR] 0.8, 95% CI 0.5–1.1), independent of the duration of diabetes. The presence of microalbuminuria, macroalbuminuria, and end-stage kidney disease was associated with 2.8, 9.2, and 18.3 times higher SMR, respectively. The increase in mortality across each stage of albuminuria was equivalent to the risk conferred by preexisting macrovascular disease. In addition, the glomerular filtration rate was independently associated with mortality, such that individuals with impaired kidney function, as well as those demonstrating hyperfiltration, had an increased risk of death. CONCLUSIONS: An independent graded association was observed between the presence and severity of kidney disease and mortality in a large contemporary cohort of individuals with type 1 diabetes. These findings highlight the clinical and public health importance of chronic kidney disease and its prevention in the management of type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic nephropathy, whether manifesting as microalbuminuria, macroalbuminuria, or a reduced glomerular filtration rate progressively augments the overall risk of macrovascular complications.118”
From Type 1 diabetes (2018) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, UACR is a continuous measurement, and differences within the normal and abnormal ranges are associated with kidney and cardiovascular outcomes (6,10,11).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, UACR is a continuous measurement, and differences within the normal and abnormal ranges are associated with kidney and cardiovascular outcomes (6,11,12).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 3×
“9* Any retinopathy 76 (29)† 1,313 (50) 420 (93)† 290 (99)† Retinopathy requiring laser therapy 27 (10)† 683 (25) 360 (78)† 288 (97)† Current smoker 98 (37)† 614 (24) 95 (22) 49 (16)† Established macrovascular disease 31 (11)† 123 (5) 116 (25)† 138 (47)† Macroalbuminuria 2 (3)† 210 (8) 338 (73)† N/A Microalbuminuria 2…”
MethodIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Doqi, K. (2002) · American Journal of Kidney Diseases · Cited by 1,285
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Conditioning Diagnostics: Collinearity and Weak Data in Regression
Goldstein, R. (1993) · Technometrics · doi:10.1080/00401706.1993.10484997 · Cited by 911
(2004) · doi:10.1177/0049124103262065 · Cited by 906
Cited by
Items 301–400 of 651
Sandholm, N., Haukka, J. K., Toppila, I., Valo, E., Harjutsalo, V., Forsblom, C. M., & Groop, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-29211-1 · Cited by 21
Self-citationKarakasis, P., Popovic, D. S., Patoulias, D., Koufakis, T., Παπάνας, Ν., Fragakis, N., & Rizzo, M. (2024) · Diabetes Therapy · doi:10.1007/s13300-023-01523-0 · Cited by 19
Wang, I., Tsai, M., Liang, C., Yen, T., Huang, C., Wen, S.-F., & Wen, C.-P. (2013) · American Journal of Nephrology · doi:10.1159/000357133 · Cited by 20
Gene expression-based analysis identified NTNG1 and HGF as biomarkers for diabetic kidney disease
Tang, Y., Dong, X., Zeng, Z., & Feng, Z. (2020) · Medicine · doi:10.1097/md.0000000000018596 · Cited by 21
Inkeri, J., Tynjälä, A., Forsblom, C. M., Liebkind, R., Tatlisumak, T., Thorn, L. M., Groop, P., Shams, S., Putaala, J., Martola, J., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01678-x · Cited by 19
“In-depth questionnaires, which have been described previously, were utilized in the collection of clinical data [10].”
MethodSelf-citationTommerdahl, K. L., Kendrick, J., Nelson, R. G., & Bjornstad, P. (2022) · Clinical Science · doi:10.1042/cs20210627 · Cited by 19
Challenges in pancreas transplantation
Sharples, E. J., Mittal, S., & Friend, P. J. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0865-x · Cited by 21
Kidney Disease: The Forgotten Legacy of Type 1 Diabetes
Thomas, M. C., Zoungas, S., Hanssen, N. M. J., McAuley, S. A., & Cooper, M. E. (2025) · Diabetes Care · doi:10.2337/dci25-0028 · Cited by 20
Self-citationMicroalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021
Rossing, P., & Epstein, M. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.11.019 · Cited by 20
Ha, K. (2024) · Theranostics · doi:10.7150/thno.95742 · Cited by 20
“Its high prevalence in type 1 diabetes patients significantly impairs life expectancy [100, 102], with chronic kidney disease and cardiac autonomic neuropathy being associated with its progression in these patients [100, 103].”
BackgroundCause-specific mortality in a cohort of Brazilian patients with type 1 diabetes
Gomes, M. B., Almeida, A. P. F., Santos, D. C., Silva, E. L. C., Cunha, E. F., & Negrato, C. A. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0975-0 · Cited by 18
Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
de Boer, I. H., & Bakris, G. L. (2018) · Diabetes Care · doi:10.2337/dci17-0053 · Cited by 18
Garofolo, M., Russo, E., Miccoli, R., Lucchesi, D., Giusti, L., Sancho‐Bornez, V., Daniele, G., Prato, S. D., & Penno, G. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.03.012 · Cited by 20
Wiromrat, P., Bjornstad, P., VINOVSKIS, C. L., Chung, L. T., Roncal, C., Pyle, L. L., Lanaspa, M. A., Johnson, R. J., Cherney, D. Z. I., Reznick-Lipina, T., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12909 · Cited by 19
Heart Failure in Type 1 Diabetes: A Complication of Concern? A Narrative Review
Gómez‐Pérez, A. M., Damas-Fuentes, M., Cornejo-Pareja, I. M., & Tinahones, F. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194497 · Cited by 20
Sigfrids, F. J., Stechemesser, L., Dahlström, E. H., Forsblom, C. M., Harjutsalo, V., Weitgasser, R., Taskinen, M., Groop, P., & the FinnDiane Study Group (2021) · Journal of Internal Medicine · doi:10.1111/joim.13412 · Cited by 19
Self-citationKidney disease: new technologies translate mechanisms to cure
O’Toole, J. F., & Sedor, J. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76825 · Cited by 21
“In cohorts of both type 1 and type 2 diabetic patients, the presence and severity of diabetic kidney disease (DKD) explains much of the excess mortality attributed to diabetes (24–27).”
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease
Afkarian, M., Hirsch, I. B., Tuttle, K. R., Greenbaum, C. J., Himmelfarb, J., & de Boer, I. H. (2014) · Physiological Reports · doi:10.14814/phy2.12010 · Cited by 18
“…Rooney et al. 2011; Zhou et al. 2012) and inhibition of the WNT pathway ameliorates podocyte injury, albuminuria, and fibrosis (Dai et al. 2009; He et al. 2009, 2011; Hao et al. 2011), though one report suggests a more complex picture with some WNT pathway activity necessary for podocyte…”
BackgroundMark, P. B., Winocour, P. H., & Day, C. (2017) · British Journal of Diabetes · doi:10.15277/bjd.2017.125 · Cited by 18
Zhang, L., Xue, S., Wu, M., & Dan, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.914587 · Cited by 19
“Formula (1) and (2) were used for obtaining Fisher’s Z and standard error (SE).”
Methodon behalf of the FinnDiane Study Group, Wadén, J. M., Dahlström, E. H., Elonen, N., Thorn, L. M., Wadén, J., Sandholm, N., Forsblom, C. M., & Groop, P. (2019) · Diabetologia · doi:10.1007/s00125-019-4883-4 · Cited by 17
Self-citationHong, Y. S., Kim, H., Zhao, D., & Cho, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204639 · Cited by 18
Eliasson, B., Lyngfelt, L., Strömblad, S.-O., Franzén, S., & Eeg‐Olofsson, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-22932-4 · Cited by 20
Marcovecchio, M. L., Tossavainen, P. H., Heywood, J. J. N., Dalton, R. N., & Dunger, D. B. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00860.x · Cited by 17
New approaches to the treatment of nephropathy in diabetes
Thomas, M. C., & Groop, P. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.591785 · Cited by 17
“For example, we have recently shown that in Finnish adults with type 1 diabetes, excess mortality associated with diabetes is almost entirely confined to those with CKD (Figure 1) [6].”
BackgroundSelf-citationZhao, F., Zhang, L., Lu, J., Guo, K., Wu, M., Yu, H., Zhang, M., Bao, Y., Chen, H., & Jia, W. (2015) · PubMed · Cited by 17
Original article. Cost-effectiveness of annual microalbuminuria screening in Thai diabetics
Srisubat, A., Sriratanaban, J., Ngamkiatphaisan, S., & Tungsanga, K. (2014) · Asian Biomedicine · doi:10.5372/1905-7415.0803.301 · Cited by 17
AGE Content of a Protein Load Is Responsible for Renal Performances: A Pilot Study
Normand, G., Lemoine, S., Villien, M., Bars, D. L., Mérida, I., Irace, Z., Troalen, T., Costes, N., & Juillard, L. (2018) · Diabetes Care · doi:10.2337/dc18-0131 · Cited by 17
Simonsen, J. R., Järvinen, A., Harjutsalo, V., Forsblom, C. M., Groop, P., & Lehto, M. J. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13138 · Cited by 20
Self-citationThe lactate-lactylation axis in renal fibrosis: potential mechanisms in diabetic kidney disease
Wei, X. S., Long, M., Yu, J., & Du, Y. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2587326 · Cited by 16
Increased incidence of neurodegenerative diseases in Finnish individuals with type 1 diabetes
Satuli-Autere, S., Harjutsalo, V., Eriksson, M. I., Hägg-Holmberg, S., Öhman, H., Claesson, T.-B., Groop, P., & Thorn, L. M. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004024 · Cited by 16
Self-citationStrategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy
Pasqua, M., Tsoukas, M. A., & Haidar, A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211035411 · Cited by 18
Serum uric acid and renal function in patients with type 1 diabetes: a nationwide study in Brazil
Pizarro, M., Santos, D. C., Barros, B. S. V., Melo, L. G. N., & Gomes, M. B. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0324-7 · Cited by 16
“Additionally, in T1D, the presence or severity of end-stage kidney disease was the main determinant of excess mortality, mainly from cardiovascular disease, independently of the use of statins or inhibitors of the renin-angiotensin system [4].”
BackgroundElevated risk of mortality in type 1 diabetes mellitus
Snell‐Bergeon, J. K., & Maahs, D. M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.245 · Cited by 18
Complications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Nesto, R. W., & Boulton, A. J. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00033-x · Cited by 22
Zhu, B. T. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022012 · Cited by 17
“Providing partial support for this suggestion, there were clinical data suggesting that DM individuals who maintained normal glomerular filtration or hyperfiltration are often better protected against the progression to end-stage diabetic kidney disease [421].”
Treatment strategies for hypertension in patients with type 1 diabetes
Katsimardou, A., Imprialos, K. P., Stavropoulos, K., Sachinidis, A. G., Doumas, M. N., & Athyros, V. G. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1729124 · Cited by 17
“As for diabetic nephropathy, it is a well-recognized risk factor for CVD and mortality in T1DM individuals [13].”
BackgroundKee, A. R., Wong, T. Y., & Li, L. (2016) · Microcirculation · doi:10.1111/micc.12327 · Cited by 15
Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
Kim, Y. C., An, J. N., Kim, J. H., Choi, Y.-W., Oh, S., Kwon, S. H., Lee, M.-Y., Lee, J.-H., Jeong, J., Lim, C. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31121-1 · Cited by 16
Schnell, O., Valensi, P. E., Standl, E., & Ceriello, A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.129 · Cited by 15
Ahola, A. J., Harjutsalo, V., Forsblom, C. M., Freese, R., Mäkimattila, S., & Groop, P. (2017) · Journal of Probiotics & Health · doi:10.4172/2329-8901.1000188 · Cited by 15
Self-citationKnorr, S., Juul, S., Bytoft, B., Lohse, Z., Clausen, T. D., Jensen, R. B., Damm, P., Beck‐Nielsen, H., Mathiesen, E. R., Jensen, D. M., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4575-5 · Cited by 17
Liu, H., Sridhar, V. S., Perkins, B. A., Rosenstock, J., & Cherney, D. Z. I. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01471-2 · Cited by 14
Terpenoids in Diabetic Nephropathy: Advances and Therapeutic Opportunities
Kaushik, M., Kaushik, A., Chaudhary, J., & Jain, A. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230901164219 · Cited by 14
Sigfrids, F. J., Lithovius, R., Groop, P., & Thorn, L. M. (2024) · Diabetic Medicine · doi:10.1111/dme.15431 · Cited by 16
Self-citationZhu, Y., Sun, L., Guo, Z., Xin, P., Huang, F., Song, L., Man, Y., Ren, M., Ma, Z., & Wang, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2538117 · Cited by 15
“…complication in patients with diabetes, exhibits a high incidence rate and has emerged as the leading cause of end-stage renal disease globally [1]. recent data from the International diabetes Federation indicate that over 500 million people worldwide are currently affected by diabetes, a…”
Sourij, H., Aberer, F., Antlanger, M., Brix, J., Cejka, D., Clodi, M., Edlinger, R., Eller, K., Horn, S., Kaser, S., et al. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-0992-y · Cited by 14
β‐Cell and renal transplantation options for diabetes
Flatt, A. J., Bennett, D., Counter, C., Brown, A. L., White, S. A., & Shaw, J. (2019) · Diabetic Medicine · doi:10.1111/dme.14177 · Cited by 16
Enuwosa, E., Gautam, L., King, L., & Chichger, H. (2021) · Nutrients · doi:10.3390/nu13082746 · Cited by 14
“In later stages of DKD, interstitial changes and glomerulopathy can result in segmental and global sclerosis, associated with albuminuria [17].”
BackgroundWu, T.-H., Chang, L.-H., Chu, C.-H., Hwu, C., Chen, H.-S., & Lin, L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266854 · Cited by 15
Prognosis and Its Predictors After Incident Stroke in Patients With Type 1 Diabetes
Hägg-Holmberg, S., Thorn, L. M., Forsblom, C. M., Gordin, D., Elonen, N., Harjutsalo, V., Liebkind, R., Putaala, J., Tatlisumak, T., & Groop, P. (2017) · Diabetes Care · doi:10.2337/dc17-0681 · Cited by 14
Self-citationThe nephrological perspective on SGLT-2 inhibitors in type 1 diabetes
Gillard, P., Schnell, O., & Groop, P. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108462 · Cited by 14
Self-citationWang, Y., Liu, T., Liu, W., Zhao, H., & Li, P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1401939 · Cited by 16
All-cause mortality and factors associated with it in Finnish patients with type 1 diabetes
Putula, E., Kauppala, T., Vanhamäki, S., Haapakoski, J., Laatikainen, T. K., & Metso, S. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108881 · Cited by 14
Majchrzak, C., Cougnard‐Grégoire, A., Goff, M. L., Féart, C., Delcourt, C., Prezelin‐Reydit, M., Helmer, C., & Rigalleau, V. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.08.009 · Cited by 13
CD2AP is associated with end-stage renal disease in patients with type 1 diabetes
Hyvönen, M. E., Ihalmo, P., Sandholm, N., Stavarachi, M., Forsblom, C. M., McKnight, A. J., Lajer, M., Maestroni, A., Lewis, G. A., Tarnow, L., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0475-9 · Cited by 13
Self-citationSelvarajah, S., Uiterwaal, C. S. P. M., Haniff, J., van der Graaf, Y., Visseren, F. L. J., Bots, M. L., & on behalf of the SMART study group (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12035 · Cited by 14
on behalf of the FinnDiane Study Group, Söderlund, J., Forsblom, C. M., Ilonen, J., Thorn, L. M., Wadén, J., Parkkonen, M., & Groop, P. (2012) · Diabetologia · doi:10.1007/s00125-012-2670-6 · Cited by 13
“In patients with type 1 diabetes, the presence of diabetic nephropathy explains most of the risk of premature death [2].”
BackgroundSelf-citationGoñi, M. J., Forga, L., Ibáñez, B., Cambra, K., Mozas, D., & Anda, E. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.11.008 · Cited by 13
Bjornstad, P., Costacou, T., Miller, R. G., Maahs, D. M., Rewers, M., Orchard, T. J., & Snell‐Bergeon, J. K. (2017) · Diabetic Medicine · doi:10.1111/dme.13430 · Cited by 14
Saygılı, S., Canpolat, N., Çakır, A. D., Konukoğlu, D., Turan, H., Çalışkan, S., Ercan, O., Evliyaoğlu, O., & Sever, L. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04526-2 · Cited by 14
Block, C. E. M. D., Shivalkar, B., Goovaerts, W., Brits, T., Carpentier, K., Verrijken, A., Hoof, V. O. V., Parizel, P. M., Vrints, C. J. M., & Gaal, L. F. V. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.11.008 · Cited by 13
“Groop PH, Thomas MC, Moran JL, Wadèn J, Thorn LM, Mäkinen VP, Rosengård-Bärlund M, Saraheimo M, Hietala K, Heikkilä O, Forsblom C; FinnDiane Study Group..”
InfluentialAfşar, B., Afşar, R. E., Sag, A. A., Kanbay, A., Korkmaz, H., Cipolla‐Neto, J., Covic, A. C., Ortíz, A., & Kanbay, M. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz198 · Cited by 14
Limonte, C. P., Lamprea-Montealegre, J. A., & Tuttle, K. R. (2024) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2024.151520 · Cited by 14
El-Samahy, M. H., Tantawy, A. A. G., Adly, A. A. M., Habeeb, N. M. M., Ismail, E. A. R., Hamed, G. M., & Eladawy, R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12484 · Cited by 12
Risk factors for decline in renal function among young adults with type 1 diabetes
Schwandt, A., Bergis, D., Denkinger, M. D., Gollisch, K. S. C., Sandig, D., Stingl, H., Zimny, S., & Holl, R. W. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.07.007 · Cited by 12
Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk
Piko, N., Bevc, S., Ekart, R., Petreski, T., Hojs, N. V., & Hojs, R. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.975 · Cited by 16
Hyvönen, M. E., Dumont, V., Tienari, J., Lehtonen, E., Ustinov, J., Havana, M., Jalanko, H., Otonkoski, T., Miettinen, P. J., & Lehtonen, S. H. (2015) · BioMed Research International · doi:10.1155/2015/102969 · Cited by 12
“…and Sanna Lehtonen1 1 Department of Pathology, Haartman Institute, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland 2 Children’s Hospital, University of Helsinki, 00290 Helsinki, Finland 3Department of Pathology, HUSLAB, Helsinki University Central Hospital, 05850 Hyvinkää,…”
BackgroundHypertension and Diabetic Nephropathy
Skov, J., Christiansen, J. S., & Poulsen, P. L. (2016) · Endocrine development · doi:10.1159/000439393 · Cited by 12
Wang, Y., Jardine, M., & Perkovic, V. (2014) · Wiley eBooks · doi:10.1002/9781118337967.ch3 · Cited by 13
Velayutham, V., Benitez‐Aguirre, P., Craig, M. E., Cho, Y. H., Liew, G., & Donaghue, K. C. (2022) · Diabetes Care · doi:10.2337/dc22-0349 · Cited by 11
Progression and regression of kidney disease in type 1 diabetes
Sigfrids, F. J., & Groop, P. (2023) · Frontiers in Nephrology · doi:10.3389/fneph.2023.1282818 · Cited by 12
Self-citationPavlakis, M., & Kher, A. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.014 · Cited by 11
Landgraf, R., Kellerer, M., Aberle, J., Fach, E.-M., Gallwitz, B., Hamann, A., Joost, H., Klein, H., Müller‐Wieland, D., Nauck, M. A., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0598-0475 · Cited by 18
on behalf of the FinnDiane Study Group, Panduru, N. M., Forsblom, C. M., Saraheimo, M., Thorn, L. M., Gordin, D., Elonen, N., Harjutsalo, V., Bierhaus, A., Humpert, P. M., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4328-x · Cited by 13
Self-citationInkeri, J., Adeshara, K. A., Harjutsalo, V., Forsblom, C. M., Liebkind, R., Tatlisumak, T., Thorn, L. M., Groop, P., Shams, S., Martola, J., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01821-8 · Cited by 11
Self-citationAlicic, R. Z., Johnson, E. J., & Tuttle, K. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00003-3 · Cited by 12
Ritsinger, V., Hero, C., Svensson, A., Saleh, N., Lagerqvist, B., Eeg‐Olofsson, K., & Norhammar, A. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487316687860 · Cited by 11
Lee, J.-H., Yang, F., Tsai, W., Lee, C.-T., Liu, S., Yang, W., & Tung, Y. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.06.022 · Cited by 11
Ahola, A. J., Saraheimo, M., Freese, R., Forsblom, C. M., Mäkimattila, S., & Groop, P. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.012 · Cited by 11
“Importantly, the long-term complications account for the majority of the increased morbidity and mortality related to diabetes [2].”
BackgroundSelf-citationMakvandi, K., Eliasson, B., Carlsen, H. K., & Baid‐Agrawal, S. (2024) · Diabetes Care · doi:10.2337/dc24-0908 · Cited by 11
Aminnejad, N., Greiver, M., & Huang, H. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000700 · Cited by 11
Emerging drugs for managing kidney disease in patients with diabetes
Thomas, M. C. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.762356 · Cited by 11
“Of these complications, chronic kidney disease (CKD) imposes some of the highest costs, both in dollars and in terms of human suffering.”
BackgroundInfluentialSelf-citationLee, M., Hong, N., Lee, Y., Kang, E. S., Soo, B., & Lee, B. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.019 · Cited by 11
Recent advances in type 1 diabetes
Kyi, M., Wentworth, J. M., Nankervis, A. J., Fourlanos, S., & Colman, P. G. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.01691 · Cited by 11
Association of lipid abnormalities and oxidative stress with diabetic nephropathy
Kachhawa, K., Agrawal, D., Rath, B., & Kumar, S. (2017) · Journal of integrative nephrology and andrology · doi:10.4103/jina.jina_1_17 · Cited by 13
Uçaktürk, S. A., Mengen, E., Elmaoğulları, S., Yücel, Ç., Yılmaz, A. A., & Çifci, A. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0373 · Cited by 10
Ahmed, S. B., & Dumanski, S. M. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.06.033 · Cited by 12
Mo, G. P., Zhu, Y., You, Y., Chen, H., Zhang, J., Ku, B., Yu, H., & Peng, Z. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s513080 · Cited by 10
“8–10 With the continuous increase of the global prevalence of diabetes, the incidence rate of DKD is also increasing year by year, which has brought a heavy burden to patients and the society.”
Sakamoto, M., Hasuzawa, N., Wang, L., Tashiro, K., Kitamura, M., Iwata, S., Wada, N., Nomura, S., Moriyama, S., Gobaru, M., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1706838 · Cited by 9
The Changing Face of Young-Onset Diabetes: Type 1 Optimism Mellowed by Type 2 Concerns
Orchard, T. J. (2013) · Diabetes Care · doi:10.2337/dc13-1457 · Cited by 9
Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes
Popovic, D. S., Patoulias, D., Gnudi, L., & Mantzoros, C. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155763 · Cited by 9
Microbubbles and Ultrasound: Therapeutic Applications in Diabetic Nephropathy
Cao, W. J., Matkar, P. N., Chen, H. H., Mofid, A., & Leong-Poi, H. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22536-4_17 · Cited by 10
Ražanskaitė-Virbickienė, D., Danytė, E., & Žalinkevičius, R. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0252-4 · Cited by 9
“diabetic nephropathy is related with the greatest risk of premature death in patients with T1D [3].”
BackgroundVitamin D and Albuminuria in Youth with and without Type 1 Diabetes
Nandi-Munshi, D., Afkarian, M., Whitlock, K. B., Crandell, J., Bell, R. A., D’Agostino, R., Saydah, S., Mottl, A. K., Dabelea, D., Black, M. H., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000475711 · Cited by 9
Balasubramani, S., Shanmugam, S., Somasundaram, E., Chandramouli, P. E., Bhaskaran, S., & Chandrasekaran, R. (2017) · Indian Journal of Dental Research · doi:10.4103/ijdr.ijdr_350_16 · Cited by 9
Sekercioglu, N., Lovblom, L. E., Bjornstad, P., Lovshin, J. A., Lytvyn, Y., Boulet, G., Farooqi, M. A., Orszag, A., LAI, V. S., TSE, J. M., et al. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1614057 · Cited by 9
Cerezo, I., Cancho, B., Sabillón, J. A. R., Sabillón, J. A. R., Álvarez, Á., Valladares, J., Gómez, J. L., Requena, J. M. R., & Robles, N. R. (2024) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.25139 · Cited by 10
DNA methylation in chronic kidney disease
Cheng, Y., Liu, P., Xie, G., Li, W., Jing, H., Chen, Y., Chen, H., Fan, Y., & Zhou, J. (2025) · BMC Nephrology · doi:10.1186/s12882-024-03916-0 · Cited by 8
“The high mortality rate in patients with diabetes is associated with the presence of DKD [31].”
Ruddiman, K. R., Bartfield, J. K., & Hirsch, I. B. (2025) · Obesity · doi:10.1002/oby.70033 · Cited by 10
“…diabetic nephropathy (albuminuria or reduced GFR) in T1D is associated with increased cardiovascular risk [49, 50] and higher overall mortality [51], the risk of morbidity and mortality for patients with preexisting kidney disease should be weighed against the potential weight loss benefit…”
Metadata
- Authors
- Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., & Forsblom, C.
- Affiliations
- Helsinki University Hospital (FI)
- Baker Heart and Diabetes Institute (AU)
- Department of Intensive Care Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia;
- Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland;
- Corresponding author
- Groop, Per-Henrik
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-04-28
- Volume
- 58
- Issue
- 7
- Pages
- 1651-1658
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2699848
- OpenAlex
- W2101457616
- Semantic Scholar
- 8c94474962d440b785728afdfb3a4ed830eedf9d
- Cited by
- 638
- References
- 49
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 30 · 2023: 38 · 2022: 59 · 2021: 43 · 2020: 40 · 2019: 48 · 2018: 55 · 2017: 43 · 2016: 40 · 2015: 41 · 2014: 54 · 2013: 40 · 2012: 23
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- Wilhelm och Else Stockmanns Stiftelse
- European Commission
- Signe ja Ane Gyllenbergin Säätiö
- Waldemar von Frenckells Stiftelse
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 1 diabetes, chronic kidney disease, all-cause mortality, diabetic nephropathy, albuminuria, microalbuminuria, macroalbuminuria, end-stage renal disease, glomerular filtration rate, hyperfiltration, standardized mortality ratio
- MeSH terms
- Adolescent, Adult, Cause of Death, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Finland, Follow-Up Studies, Glomerular Filtration Rate, Humans, Insulin, Male, Middle Aged, Severity of Illness Index, Cohort Studies, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.